Dr. Shiyan Feng
Dr. Feng currently serves as the Vice President of Science and Technology at Geneham Pharmaceutical Co., Ltd. Hers primary research focus is on the development of active ingredients from natural Chinese medicine. She has participated in three horizontal and vertical projects and has published four papers in core journals both domestically and internationally.
Hosted and participated in scientific research projects:
1. Screening of fenugreek pseudo-androgenic components
2. Industrial hemp project of the Academy of Engineering (responsible for the basic research of drug efficacy substances)
3. National Fund Regional Fund: Discovery of triterpenoid compounds in three Elsholtzia plants and research on anti-influenza virus activity (responsible for the basic research of drug efficacy substances)
Papers published in the past five years:
(1) Shi-Yan Feng, Na Jiang, Jia-Ying Yang, Lin-Yao Yang, Jiang-Chao Du, Xuan-Qin Chen, Dan Liu, Rong-Tao Li, Jin-Dong Zhong. Antiviral and anti-inflammatory activities of chemical constituents from twigs of Mosla chinensis Maxim. Nat Prod Bioprospect. 2024 May 1;14(1):26.
(2) Feng Shi-yan; Zhang Lu; Xiang Lun-li; Li Rong-tao; Chen Xuan-qin; Yu Fei; Zhong Jin-dong. Anti-influenza activity of compounds isolated from the leaves of Elsholtzia rugulosa and their chemotaxonomic significance. Biochemical Systematics and Ecology. Volume 103, Issue. 2022
(3) Feng Shiyan; Fan Lu; Wu Juan; Ye Zujun; Zhong Jindong. Chemical Constituents of Hedyotis diffusa and Their Anti-Inflammatory Activity. Chemistry of Natural Compounds. Volume 58, Issue 3. 2022. PP 531-533.
(4) Feng Z Y, Du J C, Yang J Y, Li R T, Yu F, Zhong J D. Study on the chemical constituents and anti-influenza activity of volatile oils from 5 species of Cheilaceae. Chinese Journal of Pharmaceutical Sciences. 2022,57 (11).